Thrice Acting Director Lowy lays out vision of NCI future as Bertagnolli steps in

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

“Yesterday, I went to sleep as acting NCI director, and this morning, as I woke up, I have a new boss, Monica Bertagnolli,” Douglas R. Lowy said in the morning of Oct. 3, addressing a well-caffeinated meeting of the Association of American Cancer Institutes.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Matthew Bin Han Ong
Matthew Bin Han Ong
Table of Contents

YOU MAY BE INTERESTED IN

Cristina Puig-Saus, an associate professor of microbiology, immunology and molecular genetics and surgical oncology at the David Geffen School of Medicine at UCLA and an investigator at the UCLA Health Jonsson Comprehensive Cancer Center, and her research team have received a five-year, $3.9 million grant from NCI to develop drug-based strategies that could enhance cancer immunotherapy for patients with melanoma and potentially other types of cancer. 
Matthew Bin Han Ong
Matthew Bin Han Ong

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login